Investigators have developed and tested a novel gene therapy that enters kidney cells and enables them to block complement activation. The research was presented at ASN Kidney Week 2024 ...

Mannan-binding lectin (MBL), M-, L- and H-ficolin recognize microorganisms and activate the complement system via MBL-associated serine proteases (MASPs). We investigated lectin pathway cord blood ...

InflaRx (IFRX) Company Description: InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as ...

FibroBiologics (FBLG) announced the filing of a patent application with the United States Patent and Trademark Office covering methods ...

Inhibition of the terminal complement cascade prevents the proinflammatory consequences of complement activation while preserving early complement components that are crucial for the clearance of ...